Itraconazole Oral Suspension Base
Itraconazole mixed with suspending agents, forming a bulk oral suspension base for antifungal treatment of mucosal infections. This mixed product is not dosed or retail-packed, so it is classified under tariff item 3003.90.00.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
PGA flags (2)Show detailsHide detailsHCHuman DrugsMay be requiredHCVeterinary DrugsMay be required
- HC
Human Drugs · May be required
May require HC Human Drugs depending on intended use (HC01, HC29, HC31) and Canadian product category (HC05, HC06); or intended use (HC02, HC07, HC31) and Canadian product category (HC05). Matching criteria: Starts With 3003; Starts With 3003. Logic: MATCH IF (Valid HS Code) AND (Intended Use Code) AND (Valid Canadian Product Category).
- HC
Veterinary Drugs · May be required
May require HC Veterinary Drugs depending on intended use (HC10) and Canadian product category (HC16, HC17); or intended use (HC07, HC11, HC12, HC14, HC29) and Canadian product category (HC16). Matching criteria: Starts With 3003; Starts With 3003. Logic: MATCH IF (Valid HS Code) AND (Intended Use Code) AND (Valid Canadian Product Category).
CBSA Single Window matching criteria, unknown
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the suspension is in measured doses or retail packings
Retail-packaged medicaments fall under heading 30.04.
If itraconazole is unmixed and not formulated
Pure active ingredients are classified in Chapter 29.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Confirm the suspension is not in measured doses or retail packaging
• Provide a certificate of analysis showing the mixture and therapeutic purpose
• Check if the finished suspension requires a DIN from Health Canada
Related Products under Tariff item 3003.90.00
Acyclovir Bulk Mixture
A bulk mixture of acyclovir with excipients for antiviral therapy against herpes simplex and zoster, intended for pharmaceutical formulation. Not in measured doses or retail sale, it is classified under tariff item 3003.90.00.
Amlodipine-Benazepril Granulation
A granulated mixture of amlodipine besylate and benazepril hydrochloride, two active pharmaceutical ingredients combined for blood pressure control. Supplied in bulk for tableting, it is not put up in measured doses or retail packaging, qualifying it as a mixed therapeutic medicament under tariff item 3003.90.00.
Amoxicillin-Clavulanate Bulk Powder
A bulk powder mixture of amoxicillin and clavulanic acid, a combination antibiotic for treating bacterial infections. Supplied for further pharmaceutical processing, it is not in measured doses or retail forms, fitting the scope of tariff item 3003.90.00 for mixed therapeutic medicaments.
Amphotericin B Injectable Concentrate
Amphotericin B injectable concentrate is a bulk mixture of amphotericin B with stabilizers for IV antifungal therapy against severe fungal infections. It falls under tariff item 3003.90.00 as a mixed antifungal not in retail form or measured doses, for hospital or compounding use.
Aspirin-Paracetamol Bulk Mixture
A bulk blended powder of aspirin and paracetamol for pain relief and fever reduction, intended for tablet compression in manufacturing. As a mixed medicament not put up in measured doses or retail sale, it is classified under tariff item 3003.90.00.
Atorvastatin-Ezetimibe Powder
A bulk powder of atorvastatin calcium and ezetimibe for cholesterol management, mixed for pharmaceutical manufacturing. Not in measured doses or retail packaging, it falls under tariff item 3003.90.00 as a mixed therapeutic medicament.